LexAurum Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

LexAurum Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7,050	Closed	-$1.11M	–	241
2020 Q3	$1.11M	Buy	7,050 +2,588	+58%	+$423K	0.46%	50
2020 Q2	$749K	Buy	+4,462	New	+$700K	0.41%	61
2018 Q4	–	Sell	-9,009	Closed	-$1.43M	–	154
2018 Q3	$1.43M	Buy	+9,009	New	+$1.36M	1%	29

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

LexAurum Advisors's FBT Position: Q4 2020 in Review

LexAurum Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2020, closing a stake of 7,050 shares — an estimated $1.11M sold.

LexAurum Advisors first reported a position in FBT in Q3 2018 and held it in 3 quarters. The position peaked at $1.43M in Q3 2018. 236 funds tracked by Wall St. Rank hold FBT as of Q4 2020.

LexAurum Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2020 after selling out during the quarter.
LexAurum Advisors sold 7,050 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2020, an estimated $1.11M.
LexAurum Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2018 and held it in 3 quarters.
LexAurum Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.43M in Q3 2018.
236 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2020.

Based on LexAurum Advisors's 13F filing for Q4 2020, filed 20 Jan 2021.